In the BioHealth Capital Region, where reports are stating there are 2,000 current and projected open jobs within the biotech sector, the topic of attracting and retaining talent has never been more urgent. Some companies will adapt and succeed, while others will struggle to keep up. We want to help you and your company understand the challenges, take advantage of the opportunities, and succeed in growing your business, and the biotech community, in the BioHealth Capital Region.
Betamore and Frederick Innovative Technology Center, Inc. (FITCI) are collaborating on a new, more impactful, hybrid conference event, Founder City. Founder City brings together into one event some of the [….]
Hood College to Partner with Kite Pharma to Train Employees for a New Facility in Urbana Hood College plans to partner with a pharmaceutical company to train employees for a [….]
We spoke with Dr. Emad Hassan, Chief Science Officer at Modavar Pharmaceuticals (Modavar), about the importance of effective, impactful leadership that sparks innovation and productivity. Modavar is a wholly-owned subsidiary of Indian pharma giant Cadila Pharmaceuticals. Modavar recently opened a brand new, state-of-the-art, 22,000 square foot manufacturing facility in Frederick, Maryland, adding a prestigious new life science company to the blossoming Frederick biotech hub.
Akunna Iheanacho, Ph.D., is the Scientific Director at Texcell North America, Inc., where she provides technical and scientific direction for novel assay development, virus purification efforts, and viral safety testing. She also serves as a Study Director for viral clearance studies. She is a subject matter expert with broad biotechnology experience and expertise in areas that include process development for large-scale cGMP manufacture of vaccines, AAV gene therapies, and biopharmaceutical purification.
Kemp Proteins, a leading provider of gene-to-protein and monoclonal antibody development services, announced today that the company has appointed Carter Michell, Ph.D. as its new Chief Scientific Officer (CSO). Carter will lead the scientific and technological development of Kemp Proteins as the company continues its impressive growth following its purchase by Six02 Bioservices in January 2019.
Lonza’s Walkersville, Maryland site is seeking new talent to support a growing portfolio of exciting projects. As part of this hiring campaign, the Walkersville site is hosting a Virtual Recruiting Event on January 26th so that job candidates can learn more about Lonza, its culture, and the opportunities available at the Walkersville location, which is just a short drive from downtown Frederick, Maryland, one the region’s most popular destinations.
Modavar Pharmaceuticals (Modavar), a wholly-owned subsidiary of Indian pharma giant Cadila Pharmaceuticals, recently opened a brand new, state-of-the-art, 22,000 square foot manufacturing facility in Frederick, Maryland, adding a prestigious new life science company to the blossoming Frederick biotech hub.
Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced it submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a Phase 1 clinical trial of VLX-1005, a first-in-class small molecule inhibitor of 12-Lipoxygenase in development for the treatment of heparin-induced thrombocytopenia (HIT).
2020 found the United States embroiled in a chaotic political environment, reckoning with social unrest and racial injustice, and voting in one of the most consequential presidential elections in the country’s history.
